AI is bringing sweeping changes to drug development, from how targets are discovered to optimizing clinical trials to maximize an asset’s chance for success. On a special edition of the BioCentury This Week podcast, IQVIA’s Greg Lever joins BioCentury’s analysts to discuss agentic AI’s short- and long-term prospects to help biotechs discover new targets, predict success in preclinical development, and enhance clinical operations. This episode of BioCentury This Week is sponsored by IQVIA Biotech.

View full story: https://www.biocentury.com/article/657086

#Biotech #Biopharma #DrugDevelopment #ClinicalTrials #TargetDiscovery #AgenticAI #GraphRAG #DeRisking

00:01 - Sponsor Message: IQVIA Biotech
01:22 - AI in Biotech
05:01 - Machine Learning
06:21 - Generative AI and Language Models
08:37 - Agentic AI
12:43 - AI in Target Discovery
23:44 - AI in Clinical Trial Design

To submit a question to BioCentury’s editors, email the BioCentury This Week team at [email protected].

Reach us by sending a text